YM155 exerts potent cytotoxic activity against quiescent (G0/G1) multiple myeloma and bortezomib resistant cells<i>via</i>inhibition of survivin and Mcl-1

Miyuki Ookura(University of Fukui), Akira Yoshida(Hyogo Prefectural Amagasaki General Medical Center)
Oncotarget
December 4, 2017
Cited by 7


Related Papers

No related papers found

Powered by citation graph analysis